BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2679068)

  • 1. Congenital antithrombin III deficiency. Incidence and clinical features.
    Hirsh J; Piovella F; Pini M
    Am J Med; 1989 Sep; 87(3B):34S-38S. PubMed ID: 2679068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antithrombin III deficiency in blood donors selected for personal or familial history of venous thrombosis.
    Finazzi G; Radice E; Armato A; Barbui T
    Ric Clin Lab; 1985; 15(2):173-6. PubMed ID: 4059797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review.
    Demers C; Ginsberg JS; Hirsh J; Henderson P; Blajchman MA
    Ann Intern Med; 1992 May; 116(9):754-61. PubMed ID: 1489375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
    Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
    Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous surgery in patients with congenital antithrombin III deficiency.
    Kelly MD; Rosenfeld D; Leslie GJ
    Aust N Z J Surg; 1994 Dec; 64(12):865-8. PubMed ID: 7980265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
    Büller HR; ten Cate JW
    Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary deficiency of protein C, protein S and antithrombin III.
    Vittore CP; Demos TC
    Can Assoc Radiol J; 1996 Aug; 47(4):251-6. PubMed ID: 8696990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family.
    d'Souza S; Ekert H
    Aust N Z J Med; 1984 Dec; 14(6):835-40. PubMed ID: 6598052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
    Winter JH; Fenech A; Bennett B; Douglas AS
    Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.
    Millar DS; Wacey AI; Ribando J; Melissari E; Laursen B; Woods P; Kakkar VV; Cooper DN
    Hum Genet; 1994 Nov; 94(5):509-12. PubMed ID: 7959685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.
    Tabernero MD; Tomas JF; Alberca I; Orfao A; Lopez Borrasca A; Vicente V
    Am J Hematol; 1991 Apr; 36(4):249-54. PubMed ID: 1826407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation.
    Bauer KA; Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):39S-43S. PubMed ID: 2679069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III deficiency in a Chinese family.
    Concannon AJ; Low J
    Med J Aust; 1981 May; 1(10):521-3. PubMed ID: 7254014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and features of thrombosis in children with inherited antithrombin deficiency.
    de la Morena-Barrio B; Orlando C; de la Morena-Barrio ME; Vicente V; Jochmans K; Corral J
    Haematologica; 2019 Dec; 104(12):2512-2518. PubMed ID: 30975910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
    Alving BM; Comp PC
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.